I am deeply saddened to hear of Ward’s passing. He was a friend to many of us 
and a tremendous supporter of structural biology. I knew him since his time at 
Michigan. He championed the ways through applications of new innovations 
throughout the era of synchrotron technologies and increasing awareness of the 
possibilities they brought with them. As NIH program director he was always a 
source of insight and support for prospects and possibilities. 
Robert Stroud
str...@msg.ucsf.edu
415 987 7535



> On Jul 18, 2020, at 4:36 AM, Sweet, Robert 
> <000027e0eb9d20ec-dmarc-requ...@jiscmail.ac.uk> wrote:
> 
> I'm writing to acknowledge the passing of Ward Smith during the weekend of 5 
> July. Ward got his PhD with Martha Ludwig at U. of Michigan, and then came to 
> UCLA in 1977 to join Dave Eisenberg’s group as a postdoc. During the course 
> of things, he met Cheryl Janson, a Paul Boyer postdoc, and they were married 
> in 1980.  During his time at UCLA Ward became expert in operation of the 
> Xuong/Hamlin/Nielsen multi-wire system at UCSD and tutored the UCLA users in 
> its use. In 1985 Ward and Cheryl left UCLA and went to Monsanto in St. Louis, 
> where Ward worked as a structural biologist. In 1987 they went to Agouron 
> Pharmaceuticals in San Diego. And then in 1995 went cross-country to 
> SmithKline Beecham (which became Glaxo SmithKline, merging with 
> GlaxoWellcome). 
> 
> Ward was very involved with getting IMCA set up as a functional facility for 
> pharmaceuticals at Argonne as SmithKline's representative. This experience 
> gave him significant credibility in synchrotron macromolecular 
> crystallography, and in 2003 he joined the GM/CA-CAT beamlines at the APS to 
> help Bob Fischetti and others construct that excellent facility. During this 
> time Cheryl worked at Shamrock Structures.
> 
> Ward moved to the NIH headquarters in 2007. There he took some responsibility 
> for the Protein Structure Initiative, also playing an important role in 
> supporting NIH synchrotron facilities. In 2010 he became the branch chief for 
> the Structural Genomics and Proteomics Technology Branch in the Division of 
> Cell Biology and Biophysics.  He remained in that position through 2017. At 
> the 2018 NIGMS re-organization Ward went to the Biophysics, Biomedical 
> Technology, and Computational Biosciences division as the branch chief for 
> the Biomedical Technology Branch. 
> 
> Ward helped oversee the big NIH-funded, $45 M construction of three major 
> beamlines at NSLS-II, a project called ABBIX that ran 2011-2017. In 2017 he 
> became program director for NIH support of structural biology beamlines at 
> NSLS-II and other DOE synchrotrons. 
> 
> Many knew Ward for his always calm, reasoned demeanor; he was unflappable, 
> resilient, and friendly. He was well read and devoted to his family.  
> 
> ================================================
>  Robert M. Sweet                       E-Dress:  sw...@bnl.gov
>  Scientific Advisor, CBMS: The Center for BioMolecular
>                    Structure at NSLS-II
>  Photon Sciences and Biology Dept
>  Brookhaven Nat'l Lab.
>  Upton, NY  11973     U.S.A.
>  Phones: 631 344 3401  (Office)
>                631 338 7302  (Mobile)
> ================================================
> ########################################################################
> 
> To unsubscribe from the CCP4BB list, click the following link:
> https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
> 
> This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing 
> list hosted by www.jiscmail.ac.uk, terms & conditions are available at 
> https://www.jiscmail.ac.uk/policyandsecurity/

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to